» Articles » PMID: 37548700

Health-related Quality of Life of Children with First Onset Steroid-sensitive Nephrotic Syndrome

Overview
Journal Eur J Pediatr
Specialty Pediatrics
Date 2023 Aug 7
PMID 37548700
Authors
Affiliations
Soon will be listed here.
Abstract

This study assessed HRQoL and emotional and behavioral difficulties (EBD) and associated variables in children with first onset SSNS. While relapsing steroid-sensitive nephrotic syndrome (SSNS) in children is associated with lower health-related quality of life (HRQoL), little is known about first onset. Four weeks after onset, children (2-16 years) and/or their parents who participated in a randomized placebo-controlled trial, completed the Pediatric Quality of Life Inventory 4.0 (PedsQL) and Strengths and Difficulties Questionnaire (SDQ) to measure HRQoL and EBD, respectively. Total and subscale scores and the proportion of children with impaired HRQoL (> 1 SD below the mean of the reference group) or SDQ clinical scores (< 10 and > 90 percentile) were compared to the Dutch general population (reference group). Regression analyses were used to identify associated variables. Compared to the reference group, children 8-18 years reported significantly lower total HRQoL, and physical and emotional functioning. A large proportion (> 45%) of these children had impaired HRQoL. There were no differences in HRQoL between children 2-7 years and the reference group, except for higher scores on social functioning (5-7 years). Similar proportions of SSNS and reference children scored within the clinical range of SDQ subscales. Age, sex, and steroid side-effects were negatively associated with HRQol and/or EBD.   Conclusion: This study showed that HRQoL and EBD are affected in children of different ages with first onset SSNS. This calls for more awareness from healthcare providers and routinely monitoring of HRQoL and EBD in daily clinical care to prevent worsening of symptoms.   Clinical trial registry: Netherlands Trial Register ( https://trialsearch.who.int/ ; NTR7013), date of registration: 02 June 2018. What is Known: •  Health-related quality of life (HRQoL) is lower and emotional and behavioral difficulties (EBD) is more affected in children with frequently-relapsing and steroid-dependent nephrotic syndrome. What is New: •  HRQoL and EBD are affected in children with first onset steroid-sensitive nephrotic syndrome compared to a reference group of the Dutch general population. • To what extent HRQoL and EBD are affected depends on the age of the patient.

Citing Articles

Quality of Life of Children with Idiopathic Nephrotic Syndrome.

Shukla J, Gupta A, Kalra R Indian J Nephrol. 2025; 35(2):234-242.

PMID: 40060072 PMC: 11883313. DOI: 10.25259/IJN_5_2024.


Childhood idiopathic nephrotic syndrome: recent advancements shaping future guidelines.

Chan E, Boyer O Pediatr Nephrol. 2024; .

PMID: 39724419 DOI: 10.1007/s00467-024-06634-9.


Assessment of health-related quality of life of children with idiopathic nephrotic syndrome and their caregivers in China.

Wang X, Tan D, Guan L, Shao Y, Wang J, Feng C Health Qual Life Outcomes. 2024; 22(1):94.

PMID: 39472955 PMC: 11523807. DOI: 10.1186/s12955-024-02310-6.

References
1.
Noone D, Iijima K, Parekh R . Idiopathic nephrotic syndrome in children. Lancet. 2018; 392(10141):61-74. DOI: 10.1016/S0140-6736(18)30536-1. View

2.
Berard E, Broyer M, Dehennault M, Dumas R, Eckart P, Fischbach M . [Corticosensitive nephrotic syndrome (or nephrosis) in children. Therapeutic guideline proposed by the Pediatric Society of Nephrology]. Nephrol Ther. 2006; 1(3):150-6. DOI: 10.1016/j.nephro.2005.06.003. View

3.
Tarshish P, Tobin J, Bernstein J, EDELMANN Jr C . Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol. 1997; 8(5):769-76. DOI: 10.1681/ASN.V85769. View

4.
McDonough A, Curtis J, Saag K . The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol. 2008; 20(2):131-7. DOI: 10.1097/BOR.0b013e3282f51031. View

5.
Teeninga N, Kist-van Holthe J, van Rijswijk N, de Mos N, Hop W, Wetzels J . Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome. J Am Soc Nephrol. 2013; 24(1):149-59. PMC: 3537218. DOI: 10.1681/ASN.2012070646. View